Ameriprise’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-13,169
| Closed | -$51K | – | 3837 |
|
|
2018
Q2 | $51K | Buy |
13,169
+64
| +0.5% | +$248 | ﹤0.01% | 3591 |
|
|
2018
Q1 | $83K | Buy |
+13,105
| New | +$83K | ﹤0.01% | 3560 |
|
|
2016
Q4 | – | Sell |
-1,375
| Closed | -$69K | – | 3984 |
|
|
2016
Q3 | $69K | Sell |
1,375
-81
| -6% | -$4.07K | ﹤0.01% | 3667 |
|
|
2016
Q2 | $62K | Buy |
1,456
+79
| +6% | +$3.36K | ﹤0.01% | 3654 |
|
|
2016
Q1 | $90K | Buy |
+1,377
| New | +$90K | ﹤0.01% | 3614 |
|
|
2015
Q4 | – | Sell |
-34,496
| Closed | -$2.31M | – | 3939 |
|
|
2015
Q3 | $2.31M | Sell |
34,496
-10,679
| -24% | -$715K | ﹤0.01% | 2528 |
|
|
2015
Q2 | $4.4M | Buy |
45,175
+33,116
| +275% | +$3.22M | ﹤0.01% | 2228 |
|
|
2015
Q1 | $1.13M | Sell |
12,059
-4,663
| -28% | -$436K | ﹤0.01% | 2880 |
|
|
2014
Q4 | $1.49M | Buy |
16,722
+986
| +6% | +$87.7K | ﹤0.01% | 2683 |
|
|
2014
Q3 | $1.09M | Buy |
15,736
+15,732
| +393,300% | +$1.09M | ﹤0.01% | 2760 |
|
|
2014
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5719 |
|
|
2013
Q4 | – | Sell |
-781
| Closed | -$23K | – | 5584 |
|
|
2013
Q3 | $23K | Buy |
781
+45
| +6% | +$1.33K | ﹤0.01% | 4330 |
|
|
2013
Q2 | $39K | Buy |
+736
| New | +$39K | ﹤0.01% | 3862 |
|